This version (2024/06/18 12:50) was approved by grahamw.

Hull University Teaching Hospitals NHS Trust - Nuclear Medicine

Uncontrolled if printed

SOP CodeTitleReview Date
REF005Lung Ventilation/Perfusion Referral Criteria2027-06-18


Authorised By Authorising Role Authorisation Signature
(only on master paper copy)
Date Authorised
Prof G Avery ARSAC Licence Holder 2024-06-18

REF005 - Lung Ventilation/Perfusion Imaging

See REF000 - Referring to Nuclear Medicine (HUTH) for details of how to refer.

Description

Lung ventilation can be assessed by imaging deposition of a radioactive aerosol (Tc99m DTPA) inhaled by the patient. Lung perfusion can be assessed by imaging of the distribution of Technetium-99m labelled macro-aggregates of albumin (MAA) following intravenous injection. Mismatches in ventilation and perfusion can be used to diagnose pulmonary emboli.

Three dimensional images are usually acquired combined with low dose CT (SPECT/CT).

ARSAC Licence HoldersIndication
Prof Stephen Richard Underwoodlung ventilation imaging
Prof Stephen Richard Underwoodlung perfusion imaging
Prof Ged Averylung ventilation imaging
Prof Ged Averylung perfusion imaging
Dr Najeeb Ahmedlung ventilation imaging
Dr Najeeb Ahmedlung perfusion imaging


Radiopharmaceutical CT component of SPECT/CT
Typical Radiation Dose (mSv) 2.3 1.7

Staff Entitled to Refer

All UK registered medical practitioners

Supplementary Drugs

Sodium chloride for parenteral use (0.9% w/v).

Contraindications

Patients with right to left cardiac shunt must be discussed with an ARSAC licence holder.

If the patient has pulmonary hypertension, this must be indicated on the request because the technique needs to be modified in these patients.

Clinical Indications

Suspected pulmonary embolism [1][2] A contemporaneous high quality erect chest radiograph must be available so that other clinical conditions that can causes ventilation/perfusion defects are not overlooked.
Document the degree of resolution of pulmonary embolism[1]
Pre-operative assessment eg: lung volume reduction, bronchial carcinoma[1]
Evaluate the cause of pulmonary hypertension[1]
Lung transplant evaluation[1]
Evaluate chronic pulmonary parenchymal disorders such as cystic fibrosis[1]
Confirm the presence of bronchopleural fistula[1]
Evaluate congenital heart or lung disease such as cardiac shunts, pulmonary arterial stenoses, and arteriovenous fistulae and their treatment[1]
Hepatopulmonary syndrome[3]
Log In